Skip to main content
SpringerLink
Log in

Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

An Erratum to this article was published on 22 September 2005

Abstract

Hypertrophic cardiomyopathy (HCM) is a frequent, autosomal-dominant cardiac disease and manifests predominantly as left ventricular hypertrophy. Mutations in the cardiac beta-myosin heavy chain gene (MYH7) are responsible for the disease in about 30% of cases where mutations were identified. We clinically evaluated a large group of 147 consecutive HCM patients from three cardiology centers in Germany, Poland, and Kyrgyzstan according to the same protocol. The DNA of the patients was systematically analyzed in the whole coding region of the MYH7 gene using PCR, single-strand conformation polymorphism analysis, and automated sequencing. Eleven different missense mutations (including seven novel ones) in 11 unrelated patients were identified, showing a mutation frequency of 7.5% in the study population. We further examined the families of five patients (three of German, one of Polish, and one of Kyrgyz origin) with 32 individuals in total. We observed a clear, age-dependent penetrance with onset of disease symptoms in the fourth decade of life. Genotype–phenotype correlations were different for each mutation, whereas the majority was associated with an intermediate/malign phenotype. In conclusion, we report a systematic molecular screening of the complete MYH7 gene in a large group of consecutive HCM patients, leading to a genetic diagnosis in 38 individuals. Information about the genotype in an individual from one family could be very useful for the clinician, especially when dealing with healthy relatives in doubt of their risk about developing HCM. The increasing application of genetic screening and the increasing knowledge about genotype–phenotype correlations will hopefully lead to an improved clinical management of HCM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ciro E (1983) Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy: two-dimensional echocardiographic analysis. Circulation 67:1227–1233

    Google Scholar 

  2. Maron BJ, Bonow RO, Seshagiri TNR, Roberts WC, Epstein SE (1981) Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle. Am J Cardiol 49:1838–1848

    Google Scholar 

  3. Roberts R, Sigwart U (2001) New concepts in hypertrophic cardiomyopathy, part I. Circulation 104:2113–2116

    Google Scholar 

  4. Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287:1308–1320

    Google Scholar 

  5. Seidman JG, Seidman C (2001) The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104:557–567

    Google Scholar 

  6. Marian AJ, Roberts R (2001) The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 33:655–670

    Google Scholar 

  7. Jaenicke T, Diederich KW, Haas W, Schleich J, Lichter P, Pfordt M, Bach A, Vosberg HP (1990) The complete sequence of the human b-myosin heavy chain gene and a comparative analysis of its product. Genomics 8:194–206

    Google Scholar 

  8. Ackerman MJ, Van Driest SL, Ommen SR, Will ML, Nishimura RA, Tajik AJ, Gersh BJ (2002) Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin t genes in hypertrophic cardiomyopathy. J Am Coll Cardiol 39:2042–2048

    Google Scholar 

  9. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connel J, Olsen EGJ, Thiene G, Guyarfas I (1996) Report of the 1995 WHO/ISFC Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842

    Google Scholar 

  10. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M (1997) Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 77:130–132

    Google Scholar 

  11. Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) The Committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1083

    Google Scholar 

  12. Lahiri DK, Nurnberger JI (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444

    Google Scholar 

  13. Jääskeläinen P, Soranta M, Miettinen R, Saarinen L, Pihlajamäki J, Silvennoinen K, Tikanoja T, Laakso M, Kuusisto J (1998) The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. J Am Coll Cardiol 32:1709–1716

    Google Scholar 

  14. Mörner S, Richard P, Kazzam E, Hellman U, Hainque B, Schwartz K, Waldenström A (2003) Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. J Mol Cell Cardiol 35:841–849

    Google Scholar 

  15. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichreau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M (2003) Hypertrophic cardiomyopathy—distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107:2227–2232

    Google Scholar 

  16. Van Driest SL, Jaeger MA, Ommen SR, Will ML, Gersh BJ, Tajik AJ, Ackerman MJ (2004) Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 44:602–610

    Google Scholar 

  17. Erdmann J, Daehmlow S, Wischke S, Senyuwa M, Werner U, Raible J, Tanis N, Dyachenko S, Hummel M, Hetzer R, Regitz-Zagrosek V (2003) Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin Genet 64:339–349

    Google Scholar 

  18. Hougs L, Havndrup O, Bundgaard H, Kober L, Vuust J, Larsen LA, Christiansen M, Andersen PS (2005) One third of Danish hypertrophic cardiomyopathy patients have mutations in MYH7 rod region. Eur J Hum Genet 13:161–165

    Google Scholar 

  19. Hoffmann B, Schmidt-Traub H, Perrot A, Osterziel KJ, Geßner R (2001) First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Human Mutat 17:524

    Google Scholar 

  20. Geier C, Perrot A, Özcelik C, Binner P, Counsell D, Hoffmann K, Pilz B, Martiniak Y, Gehmlich K, van der Ven PFM, Fürst DO, Vornwald A, von Hodenberg E, Nürnberg P, Scheffold T, Dietz R, Osterziel KJ (2003) Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 107:1390–1395

    Google Scholar 

  21. Vidal-Puig A, Moller DE (1994) Comparative sensitivity of alternative single-strand conformation polymorphism (SSCP) methods. Biotechniques 17:490–496

    Google Scholar 

  22. Jordanova A, Kalaydjieva L, Savov A, Claustres M, Schwarz M, Estivill X, Angelicheva D, Haworth A, Casals T, Kremensky I (1997) SSCP analysis: a blind sensitivity trail. Human Mutat 10:65–70

    Google Scholar 

  23. Fananapazir L, Dalakas MC, Cyran F, Cohn G, Epstein ND (1993) Missense mutations in the beta-myosin heavy chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 90:3993–3997

    Google Scholar 

  24. Woo A, Rakowski H, Liew JC, Zhao MS, Liew CC, Parker TG, Zeller M, Wigle ED, Sole MJ (2003) Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis. Heart 89:1179–1185

    Google Scholar 

  25. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE (1998) Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338:1248–1257

    Google Scholar 

  26. Arad M, Seidman JG, Seidman CE (2002) Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet 11:2499–2506

    Google Scholar 

  27. Blair E, Redwood C, Oliveira M, Moolman-Smook JC, Brink P, Corfield VA, Östman-Smith I, Watkins H (2002) Mutations in the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy. Circ Res 90:263–269

    Google Scholar 

  28. Lowey S (2002) Functional consequences of mutations in the myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy. Trends Cardiovasc Med 12:348–354

    Google Scholar 

Download references

Acknowledgements

The authors declare that there are no conflicts of interest. We thank the families for their cooperation in this study. Further, we thank all of our colleagues in the three hospitals for invaluable help in the recruitment of patients. Especially, we thank U. Weiher and A. Köstner for excellent technical assistance. This study was supported by a grant-in-aid from Charité-Universitätsmedizin, Berlin.

Author information

Authors and Affiliations

  1. Kardiologie am Campus Buch und Virchow-Klinikum, Charité-Universitätsmedizin Berlin und Max-Delbrück-Centrum für Molekulare Medizin, Wiltbergstrasse 50, 13125, Berlin, Germany

    Andreas Perrot, Nana Bit-Avragim, Zhyldyz Kabaeva, Rainer Dietz & Karl Josef Osterziel

  2. Institut für Laboratoriumsmedizin und Pathobiochemie am Campus Virchow-Klinikum, Charité-Universitätsmedizin, Berlin, Germany

    Hajo Schmidt-Traub, Bernard Hoffmann, Matthias Prager & Reinhard Geßner

  3. National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

    Raisa I. Rudenko, Dinara A. Usupbaeva, Bakytbek Imanov & Mirsaid M. Mirrakhimov

  4. Third Department of Cardiology, Silesian School of Medicine, Katowice, Poland

    Anna Wycisk & Michal Tendera

Authors
  1. Andreas Perrot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hajo Schmidt-Traub
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernard Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matthias Prager
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nana Bit-Avragim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Raisa I. Rudenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dinara A. Usupbaeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zhyldyz Kabaeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bakytbek Imanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Mirsaid M. Mirrakhimov
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Rainer Dietz
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Anna Wycisk
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Michal Tendera
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Reinhard Geßner
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Karl Josef Osterziel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Perrot.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s00109-005-0722-9

Andreas Perrot and Hajo Schmidt-Traub contributed equally to this work

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perrot, A., Schmidt-Traub, H., Hoffmann, B. et al. Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Mol Med 83, 468–477 (2005). https://doi.org/10.1007/s00109-005-0635-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-005-0635-7

Keywords

Search

Navigation